MRK Financial Facts
Net Income Attributable to Merck & Co., Inc.: 7.95BTaxes on Income: 2.75B
See Full Income Statement
Short-term investments: 293.1M
Total Merck & Co., Inc. stockholders' equity: 15.87B
See Full Balance Sheet
Merck & Co. Inc. (MRK) Earnings
|
Expand Research on MRK
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +8.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/28/22 | Q222 | N/A | $1.70 | N/A | N/A | $13.89B | N/A | N/A | N/A | ||
| 4/28/22 | Q122 | $2.14 | $1.83 | +$0.31 | $15.9B | $14.71B | N/A | ![]() | ![]() | Details | |
| 2/3/22 | Q421 | $1.80 | $1.56 | +$0.24 | $13.5B | $13.46B | N/A | ![]() | ![]() | Details | |
| 10/28/21 | Q321 | $1.75 | $1.55 | +$0.20 | $13.2B | $12.33B | N/A | ![]() | ![]() | Details | |
| 7/29/21 | Q221 | $1.31 | $1.48 | -$0.17 | $11.4B | $11.7B | N/A | ![]() | ![]() | Details | |
| 4/29/21 | Q121 | $1.40 | $1.63 | -$0.23 | $12.1B | $12.66B | N/A | ![]() | ![]() | Details | |
| 2/4/21 | Q420 | $1.32 | $1.38 | -$0.06 | $12.5B | $12.68B | N/A | ![]() | ![]() | Details | |
| 10/27/20 | Q320 | $1.74 | $1.43 | +$0.31 | $12.6B | $12.17B | N/A | ![]() | ![]() | Details |

